Brief: Eton Pharmaceuticals Q4 Net Income USD -2.256 Million
14/03/2024 20:01
Mar 14 (Reuters) - Eton Pharmaceuticals Q4 basic EPS USD -0.09. * Q4 EPS USD -0.09
Recent news on Eton Pharmaceuticals
See all newsBrief: Eton Pharmaceuticals Under Agreement, Co Pays Aquestive Upfront License Fee Of $10 Million - SEC Filing
Aquestive rises on US licensing deal for seizure drug with Eton Pharma
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer